Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colitis, Ulcerative | 26 | 2025 | 763 | 3.420 |
Why?
|
| Pouchitis | 9 | 2025 | 55 | 2.330 |
Why?
|
| Crohn Disease | 14 | 2023 | 765 | 1.770 |
Why?
|
| Proctocolectomy, Restorative | 8 | 2025 | 105 | 1.690 |
Why?
|
| Colonic Pouches | 8 | 2025 | 85 | 1.590 |
Why?
|
| Inflammatory Bowel Diseases | 10 | 2025 | 599 | 1.160 |
Why?
|
| Ustekinumab | 2 | 2020 | 52 | 0.790 |
Why?
|
| Capsule Endoscopes | 1 | 2017 | 5 | 0.570 |
Why?
|
| Ileal Neoplasms | 1 | 2017 | 9 | 0.570 |
Why?
|
| Dysbiosis | 2 | 2016 | 81 | 0.550 |
Why?
|
| Transcriptome | 2 | 2025 | 674 | 0.550 |
Why?
|
| Foreign Bodies | 1 | 2017 | 66 | 0.530 |
Why?
|
| Gastrointestinal Agents | 4 | 2020 | 173 | 0.460 |
Why?
|
| Intestinal Mucosa | 4 | 2019 | 807 | 0.440 |
Why?
|
| Retrospective Studies | 23 | 2025 | 9330 | 0.430 |
Why?
|
| Microbiota | 3 | 2016 | 410 | 0.430 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 243 | 0.420 |
Why?
|
| Antibodies, Monoclonal, Humanized | 4 | 2019 | 962 | 0.410 |
Why?
|
| Intestines | 2 | 2016 | 416 | 0.400 |
Why?
|
| Colitis | 3 | 2021 | 249 | 0.390 |
Why?
|
| Colon | 6 | 2025 | 522 | 0.370 |
Why?
|
| Remission Induction | 8 | 2023 | 745 | 0.370 |
Why?
|
| Biological Products | 2 | 2025 | 163 | 0.360 |
Why?
|
| Autophagy | 1 | 2012 | 160 | 0.350 |
Why?
|
| Adipose Tissue | 1 | 2012 | 263 | 0.340 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 1182 | 0.340 |
Why?
|
| Ileum | 5 | 2025 | 168 | 0.320 |
Why?
|
| Postoperative Complications | 7 | 2025 | 2342 | 0.320 |
Why?
|
| Humans | 42 | 2025 | 90640 | 0.310 |
Why?
|
| Cyclosporine | 2 | 2019 | 239 | 0.300 |
Why?
|
| Treatment Outcome | 12 | 2023 | 8379 | 0.290 |
Why?
|
| Adult | 20 | 2025 | 26953 | 0.280 |
Why?
|
| Inflammation | 6 | 2023 | 990 | 0.280 |
Why?
|
| Interleukin-10 | 3 | 2017 | 155 | 0.270 |
Why?
|
| Bile Acids and Salts | 2 | 2024 | 69 | 0.270 |
Why?
|
| Male | 23 | 2025 | 42967 | 0.260 |
Why?
|
| Immunosuppressive Agents | 3 | 2020 | 984 | 0.250 |
Why?
|
| Bacteroides fragilis | 2 | 2023 | 46 | 0.250 |
Why?
|
| Oxadiazoles | 1 | 2023 | 38 | 0.220 |
Why?
|
| Indans | 1 | 2023 | 35 | 0.220 |
Why?
|
| Calcineurin Inhibitors | 2 | 2021 | 53 | 0.210 |
Why?
|
| Ulcer | 2 | 2022 | 37 | 0.210 |
Why?
|
| Phenotype | 3 | 2025 | 2473 | 0.210 |
Why?
|
| Gastrointestinal Tract | 2 | 2015 | 192 | 0.210 |
Why?
|
| Female | 19 | 2025 | 46894 | 0.200 |
Why?
|
| Enterocolitis | 1 | 2022 | 13 | 0.200 |
Why?
|
| Infliximab | 2 | 2020 | 159 | 0.200 |
Why?
|
| Opportunistic Infections | 1 | 2022 | 60 | 0.200 |
Why?
|
| Steroids | 2 | 2020 | 173 | 0.200 |
Why?
|
| Recurrence | 6 | 2021 | 1162 | 0.190 |
Why?
|
| Treatment Failure | 2 | 2019 | 282 | 0.190 |
Why?
|
| Piperidines | 2 | 2022 | 163 | 0.190 |
Why?
|
| Prospective Studies | 6 | 2023 | 4348 | 0.190 |
Why?
|
| Cytomegalovirus Infections | 1 | 2022 | 153 | 0.180 |
Why?
|
| Colonic Diseases | 1 | 2021 | 61 | 0.180 |
Why?
|
| Epigenesis, Genetic | 1 | 2025 | 526 | 0.180 |
Why?
|
| Pyoderma Gangrenosum | 1 | 2020 | 19 | 0.170 |
Why?
|
| Surgical Stomas | 1 | 2020 | 22 | 0.170 |
Why?
|
| Biosimilar Pharmaceuticals | 1 | 2020 | 25 | 0.170 |
Why?
|
| Vitamin D Deficiency | 1 | 2021 | 104 | 0.170 |
Why?
|
| Aspirin | 1 | 2021 | 162 | 0.170 |
Why?
|
| Maintenance Chemotherapy | 1 | 2019 | 84 | 0.160 |
Why?
|
| Drug Substitution | 1 | 2019 | 27 | 0.160 |
Why?
|
| Drug Resistance | 1 | 2019 | 234 | 0.160 |
Why?
|
| Ileal Diseases | 1 | 2019 | 26 | 0.160 |
Why?
|
| Induction Chemotherapy | 1 | 2019 | 153 | 0.160 |
Why?
|
| Severity of Illness Index | 6 | 2020 | 1882 | 0.160 |
Why?
|
| Follow-Up Studies | 5 | 2025 | 3698 | 0.160 |
Why?
|
| Janus Kinase Inhibitors | 1 | 2019 | 23 | 0.160 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 112 | 0.150 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2019 | 163 | 0.150 |
Why?
|
| Pyrroles | 1 | 2019 | 173 | 0.150 |
Why?
|
| Middle Aged | 13 | 2025 | 26347 | 0.140 |
Why?
|
| Histocytochemistry | 1 | 2017 | 130 | 0.140 |
Why?
|
| Secondary Prevention | 1 | 2018 | 162 | 0.140 |
Why?
|
| Radiography, Abdominal | 1 | 2017 | 70 | 0.140 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2017 | 115 | 0.140 |
Why?
|
| Microscopy | 1 | 2017 | 89 | 0.140 |
Why?
|
| Anastomosis, Surgical | 3 | 2025 | 277 | 0.140 |
Why?
|
| Bacteroides | 1 | 2016 | 35 | 0.130 |
Why?
|
| Gastrointestinal Motility | 1 | 2016 | 25 | 0.130 |
Why?
|
| Pyrimidines | 1 | 2019 | 371 | 0.130 |
Why?
|
| Colectomy | 3 | 2025 | 175 | 0.130 |
Why?
|
| Chronic Disease | 1 | 2019 | 959 | 0.130 |
Why?
|
| Clostridium Infections | 1 | 2018 | 125 | 0.130 |
Why?
|
| Administration, Rectal | 1 | 2015 | 12 | 0.130 |
Why?
|
| Genome, Bacterial | 1 | 2016 | 150 | 0.130 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2016 | 91 | 0.120 |
Why?
|
| Mucin-2 | 1 | 2015 | 12 | 0.120 |
Why?
|
| C-Reactive Protein | 3 | 2023 | 196 | 0.120 |
Why?
|
| Surgical Wound Infection | 1 | 2017 | 205 | 0.120 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 237 | 0.120 |
Why?
|
| Disease Progression | 2 | 2019 | 1486 | 0.110 |
Why?
|
| Acute Kidney Injury | 1 | 2018 | 320 | 0.110 |
Why?
|
| Young Adult | 6 | 2025 | 6426 | 0.110 |
Why?
|
| Metagenome | 1 | 2014 | 106 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 806 | 0.110 |
Why?
|
| Immune System | 1 | 2014 | 98 | 0.110 |
Why?
|
| Dexamethasone | 1 | 2015 | 345 | 0.110 |
Why?
|
| Cohort Studies | 4 | 2022 | 2891 | 0.110 |
Why?
|
| Colonoscopy | 3 | 2019 | 281 | 0.100 |
Why?
|
| Autophagy-Related Proteins | 1 | 2012 | 22 | 0.100 |
Why?
|
| Beclin-1 | 1 | 2012 | 15 | 0.100 |
Why?
|
| Risk Factors | 5 | 2025 | 5583 | 0.100 |
Why?
|
| Endoscopy | 3 | 2021 | 353 | 0.100 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2012 | 198 | 0.090 |
Why?
|
| Leukocyte L1 Antigen Complex | 2 | 2023 | 49 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2012 | 184 | 0.090 |
Why?
|
| Genome | 1 | 2014 | 393 | 0.090 |
Why?
|
| Fatty Acids, Volatile | 1 | 2011 | 32 | 0.090 |
Why?
|
| Dialysis Solutions | 1 | 1990 | 7 | 0.090 |
Why?
|
| Lactates | 1 | 1990 | 36 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2011 | 79 | 0.090 |
Why?
|
| Butyrates | 1 | 2011 | 50 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2016 | 1384 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2012 | 679 | 0.080 |
Why?
|
| Postoperative Period | 2 | 2021 | 301 | 0.080 |
Why?
|
| Biopsy | 1 | 2012 | 1192 | 0.080 |
Why?
|
| Aged | 4 | 2020 | 19424 | 0.080 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2015 | 526 | 0.070 |
Why?
|
| Inpatients | 2 | 2021 | 313 | 0.070 |
Why?
|
| Drug Administration Schedule | 2 | 2019 | 866 | 0.070 |
Why?
|
| Renal Dialysis | 1 | 1990 | 339 | 0.070 |
Why?
|
| Hemodynamics | 1 | 1990 | 739 | 0.070 |
Why?
|
| Propensity Score | 2 | 2018 | 154 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 2 | 2022 | 923 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 2705 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2011 | 572 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2012 | 2034 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2011 | 561 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2012 | 1232 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2020 | 705 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 2364 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 1286 | 0.060 |
Why?
|
| Enterocytes | 1 | 2025 | 26 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 3 | 2017 | 3278 | 0.060 |
Why?
|
| Prognosis | 2 | 2025 | 3813 | 0.060 |
Why?
|
| Amines | 1 | 2024 | 28 | 0.060 |
Why?
|
| Amides | 1 | 2024 | 54 | 0.060 |
Why?
|
| Bile | 1 | 2023 | 60 | 0.060 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2024 | 85 | 0.050 |
Why?
|
| Catalysis | 1 | 2024 | 210 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2025 | 1462 | 0.050 |
Why?
|
| Amino Acids | 1 | 2024 | 250 | 0.050 |
Why?
|
| Immunologic Factors | 1 | 2023 | 172 | 0.050 |
Why?
|
| Cytomegalovirus | 1 | 2022 | 82 | 0.050 |
Why?
|
| Osteonectin | 1 | 2022 | 22 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2017 | 2042 | 0.050 |
Why?
|
| Ostomy | 1 | 2020 | 15 | 0.040 |
Why?
|
| Time Factors | 2 | 2019 | 5366 | 0.040 |
Why?
|
| Vitamin D | 1 | 2021 | 269 | 0.040 |
Why?
|
| Prednisolone | 1 | 2018 | 40 | 0.040 |
Why?
|
| Injections, Intravenous | 1 | 2018 | 238 | 0.040 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2017 | 16 | 0.040 |
Why?
|
| Leukocyte Common Antigens | 1 | 2017 | 48 | 0.040 |
Why?
|
| Dextran Sulfate | 1 | 2017 | 69 | 0.040 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2017 | 70 | 0.040 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2019 | 131 | 0.040 |
Why?
|
| Acute Disease | 1 | 2019 | 854 | 0.040 |
Why?
|
| Immunity, Mucosal | 1 | 2017 | 70 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2019 | 671 | 0.040 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 123 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 2017 | 170 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2017 | 94 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 854 | 0.030 |
Why?
|
| Medical Records | 1 | 2017 | 120 | 0.030 |
Why?
|
| Mucous Membrane | 1 | 2016 | 83 | 0.030 |
Why?
|
| Tight Junctions | 1 | 2017 | 151 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2018 | 188 | 0.030 |
Why?
|
| Metagenomics | 1 | 2016 | 93 | 0.030 |
Why?
|
| Illinois | 1 | 2017 | 491 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1873 | 0.030 |
Why?
|
| Homeostasis | 1 | 2017 | 425 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2015 | 147 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2017 | 1132 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2017 | 314 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2015 | 245 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 374 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2015 | 252 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 1397 | 0.030 |
Why?
|
| Hospitalization | 1 | 2019 | 899 | 0.030 |
Why?
|
| Chicago | 1 | 2018 | 1441 | 0.030 |
Why?
|
| Feces | 1 | 2015 | 335 | 0.030 |
Why?
|
| Pregnancy | 1 | 2020 | 3070 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1088 | 0.030 |
Why?
|
| Animals | 3 | 2017 | 27715 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 349 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2017 | 2895 | 0.020 |
Why?
|
| Mice | 2 | 2016 | 11949 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2019 | 2338 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 1738 | 0.020 |
Why?
|
| Child | 1 | 2022 | 7219 | 0.020 |
Why?
|
| Blood Gas Analysis | 1 | 1990 | 38 | 0.020 |
Why?
|
| Bicarbonates | 1 | 1990 | 58 | 0.020 |
Why?
|
| Acetates | 1 | 1990 | 67 | 0.020 |
Why?
|
| Lactic Acid | 1 | 1990 | 95 | 0.020 |
Why?
|
| Phosphorus | 1 | 1990 | 117 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 2409 | 0.020 |
Why?
|
| Potassium | 1 | 1990 | 258 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2011 | 1049 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2017 | 3431 | 0.020 |
Why?
|
| Blood Pressure | 1 | 1990 | 906 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 1990 | 1727 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 1990 | 417 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 9354 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1695 | 0.010 |
Why?
|